Analytical Data
-
Gene name
C14orf28
- Application
-
Alternative Names
C14orf28; DRIP1Uncharacterized Protein C14orf28; Dopamine receptor-interacting Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q4W4Y0
-
Expression Region
1-310 aa
-
AA Sequence
MKTLFEEIKASIKNNYNQDRSFCRPVLPWGGVFTIKAGRKAVSCTPLYVEIRLKNTCTIDGFLMLLYVILNENENFPRELSLHFGREFVDCFLYLMDTYSFTTVKLLWIWDKMEKQQYKSEVHKASLIIDLFGNEHDNFTKNLENLMSTIQESYCSNWRCPTRVQEDQQRTININPPQEIPHGNLIRLAVNELFCSKIELCEEHGCGGLREFSQRIFCHGAPPFVVLNMQHWKSEDLAYVPYYLDLSDHKYLLEGATLFNKEEHHYSAAFQIGGHWMHYDGLRNVNLILLNKPPEFLLLSSLVYIRATEK
-
Molecular Weight
62.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C14orf28, also known as Chromosome 14 Open Reading Frame 28, is a gene located on chromosome 14 that has garnered attention in recent years due to its potential implications in various biological processes and diseases. Initially identified through genomic studies, the protein encoded by C14orf28 remains largely uncharacterized, prompting researchers to investigate its structure, function, and role in human health. Preliminary studies suggest that C14orf28 may be involved in cellular differentiation and growth regulation, as well as potentially contributing to tumorigenesis. Enhanced understanding of this protein could reveal its significance in cancer research, particularly in models of solid tumors. Recombinant protein technology has become essential in these investigations, allowing for the production of C14orf28 in sufficient quantities for functional assays and structural analyses. By generating and purifying the recombinant form of C14orf28, researchers are equipping themselves with tools necessary for elucidating its function, delineating its interactions with other cellular components, and exploring its involvement in signaling pathways. These studies are vital for assessing the biological role of C14orf28 and its potential as a therapeutic target or biomarker in diseases such as cancer, thereby advancing the field of molecular biology and contributing to the development of novel strategies for disease management. As more data accumulates, the full potential of C14orf28 in health and disease will become clearer, offering new avenues for biomedical research and intervention.
